EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Diagnostic accuracy of special AT-rich sequence-binding protein 2 immunohistochemistry for identifying colorectal tumor origin: A systematic review and meta-analysis

Syed Bilal Tanvir, Ali Shariq, Saba Farrukh, Sumaira Ahmed

International Journal of Health Sciences · 2026-11-12 · 20 · 244-257

DOI: 10.25259/ijhs_51_2026 ↗
AbstractBibliografische Angaben

Abstract

Objectives: Special AT-rich sequence-binding protein 2 (SATB2) is an immunohistochemical marker proposed for identifying colorectal origin in primary and metastatic tumors, but reported accuracy varies, and no pooled estimate restricted to verifiable data exists. We performed a systematic review and diagnostic test accuracy meta-analysis of SATB2 immunohistochemistry (IHC) for distinguishing colorectal carcinoma from non-colorectal malignancies. Methods: MEDLINE, Embase, and Web of Science were searched from inception to February 16, 2026, for English- language studies reporting SATB2 IHC against a histopathological reference standard with a non-colorectal comparator. Study selection and data extraction were performed in duplicate, and risk of bias was assessed with quality assessment of diagnostic accuracy studies-2. Studies were pooled only where a complete 2 × 2 table was verifiable against the source publication. Pooled sensitivity and specificity were estimated with a bivariate random- effects model, and positive and negative likelihood ratios (LR+ and LR−) and the diagnostic odds ratio (DOR) with random-effects models on the log scale. The review was registered in International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD420261396459; retrospective registration). Results: Five studies were included in the qualitative synthesis. Three non-overlapping patient cohorts from two source publications (the resection and biopsy cohorts of Zhang 2018 and Elnady 2022; 274 colorectal and 442 non-colorectal cases) provided verifiable 2 × 2 data for pooling. The pooled sensitivity was 93.9% (95% confidence interval [CI] 90.3–96.3) and the pooled specificity 97.5% (95% CI 95.5–98.6). The pooled LR+ was 37.4 (95% CI 20.9–67.1), the LR− 0.063 (95% CI 0.039–0.101), and the DOR 630 (95% CI 277–1432). Little statistical heterogeneity was detected, though with three cohorts, these estimates have very limited power. Leave-one-out and Zhang-cohort sensitivity analyses did not materially change the estimates. Conclusion: In this limited evidence base, SATB2 IHC was highly accurate for identifying colorectal origin and may be useful as one component of a panel-based diagnostic approach, interpreted alongside morphology, clinical context, and the local staining protocol. The estimates rest on three non-overlapping cohorts from two publications and should be regarded as preliminary rather than establishing performance across all primary, metastatic, biopsy, and carcinoma-of-unknown-primary settings.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →